Mycoplasma pneumoniae (M. pneumoniae) continues to pose a significant disease burden
on global public health as a respiratory pathogen. The antimicrobial resistance among M …

In 2023, through an ongoing respiratory pathogen surveillance system, we observed from
mid-September onwards, an increase of respiratory illness among children aged≤ 15 years …

(MRMP) outbreak. 2 On the basis of more than 30000 PCR tests and bronchoscopy findings
(appendix p 3) in a paediatric hospital in east China from 2017 to 2023, we found a …

Summary Background Lower respiratory infections (LRIs) are a major global contributor to
morbidity and mortality. In 2020–21, non-pharmaceutical interventions associated with the …

Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary
manifestations. We observed a rise in admissions due to M. pneumoniae infections starting …

Abstract In the Asia-Pacific region, Mycoplasma pneumoniae (MP) could be a notable
pathogen responsible for adult community-acquired pneumonia (CAP), with varying …

Backgrounds Mycoplasma pneumoniae (M. pneumoniae) is a common pathogen causing
respiratory diseases in children. This study aimed to characterize epidemiological and …

Abstract In October and November 2023, hospitals in the major cities of Beijing and Liaoning
in northern China reported a surge in cases of pneumonia in children, with some hospitals …

Background Mycoplasma pneumoniae infections resurged globally in 2023–2024 after a
three-year decline during the COVID-19 pandemic. We explored the incidence and severity …

We report a large-scale outbreak of Mycoplasma pneumoniae respiratory infections
encompassing 218 cases (0.8% of 26,449 patients tested) during 2023–2024 in Marseille …